The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination
- PMID: 34101973
- PMCID: PMC9771119
- DOI: 10.1111/jth.15421
The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination
Keywords: AHA; COVID-19; SARS-CoV-2 vaccine; acquired hemophilia A; hemostasis.
Comment in
-
Autoimmunity after Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired Hemophilia A.Thromb Haemost. 2021 Dec;121(12):1674-1676. doi: 10.1055/a-1579-5396. Epub 2021 Sep 16. Thromb Haemost. 2021. PMID: 34352911 No abstract available.
Comment on
-
A case report of acquired hemophilia following COVID-19 vaccine.J Thromb Haemost. 2021 Jun;19(6):1515-1518. doi: 10.1111/jth.15291. Epub 2021 May 10. J Thromb Haemost. 2021. PMID: 33783953 Free PMC article.
References
-
- https://www.covid19.admin.ch/en/epidemiologic/vacc‐doses, online open Accessed April 20, 2021.
-
- https://www.bfs.admin.ch/bfs/en/home/statistics/population/effectif‐chan..., online open. Accessed April 20, 2021.
-
- Collins P.W., Hirsch S., Baglin T.P., et al. Acquired hemophilia A in the United Kingdom: a 2‐year national surveillance study by the United Kingdom haemophilia centre doctors’ organisation. Blood. 2007;109(5):1870–1877. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
